DEVELOPERS HAVE UNDERTAKEN MULTIPLE INITIATIVES, FOCUSED ON GAINING INSURANCE COVERAGE AND FINANCIAL ASSISTANCE

Comments · 211 Views

As of today, most of the top revenue generating drugs, across the globe, are biologics. During our biologics market research

The “Top Selling Biologics Market, report features an extensive study of the current market landscape and future potential of the top selling biologics available for the treatment of a variety of disease indications.

 

As of today, most of the top revenue generating drugs, across the globe, are biologics. During our biologics market research, we were able to identify 67 top selling biologics (revenues equal to or above USD 500 million in 2020).  The manufacturing process of biologics is different from traditional small molecules. It can take up to 3 to 4 years to complete a clinical trial study for a single biologic, which leads to an increase in the manufacturing costs of these products.

 

To request a sample report: https://www.rootsanalysis.com/reports/top-selling-biologics-market/request-sample.html

 

  As per publicly available information, the cost of manufacturing of biologics range between USD 95 and USD 225, per gram. In addition, RD costs associated with biologics is higher (USD 391 million per candidate), as compared to that of small molecules (USD 309 million per drug). Annual treatment cost is the annual cost incurred by a patient during the course of drug treatment.

 

 

To order customize report: https://www.rootsanalysis.com/reports/top-selling-biologics-market/request-customization.html

 

 

Large number of top selling biologics are targeting the autoimmune disorders. During our research, majority (15) of the top selling biologics targeting autoimmune disorders are monoclonal antibodies. In addition, Soliris has the highest annual treatment cost of around USD 700,000. The annual cost of treatment of Soliris is relatively higher due to the fact that these biologics target a very small patient population, suffering from rare disorders. Developers of such therapies tend to heavily mark up such products in order to recover their respective RD expenditures.

 

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/top-selling-biologics-market.html

 

You may also be interested in the following reports:

  1. Antibody Drug Conjugates Market
  2. Global (CAR-T, TCR, and TIL) T-Cell Therapies Market (5th Edition)
  3. Bispecific Antibody Therapeutics Market
  4. Genome Editing Services Market

 

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

Comments